πŸ‡ΊπŸ‡Έ FDA
Patent

US 11672775

Treprostinil prodrugs

granted A61KA61K31/192A61K31/216

Quick answer

US patent 11672775 (Treprostinil prodrugs) held by United Therapeutics Corporation expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/192, A61K31/216, A61K31/222, A61K31/265